How early in the development of a new medicine should thEarly collaboration - a recipe for solutions: drug development and treatment strategies may go hand in hand.e discussion between...
Enhancement of the EUPATI industry guidance Background/Rationale for the documents During the PARADIGM project further expansion of specific sections of the EUPATI Guidance for Patient...
Expert melanoma nurses and advocacy group experts held a Melanoma board meeting to explore perceptions about novel treatments and scientific developments in the management of melanoma.
Novo-Nordisk, a pharmaceutical company, does user research with patients to enhance understanding of patients and to develop products that meet users’ needs.
Early Clinical Development refers generally to the first studies of a medicine in humans – typically known as Phase I and Phase II trials. Studies in early clinical development...
Safety communication is put in place to communicate adverse reactions or any safety findings to regulators, healthcare providers and patients. Safety communications are provided by marketing authorisation holders and...
A falsified medicine is a fake that passes itself off as a real, authorised medicine but contains poor quality or falsified ingredients, no ingredients or in the wrong dose...
During clinical development the manufacturing and distribution facilities available may not be suitable for a trial medicine (investigational medicinal product (IMP)), however, IMPs must be manufactured, stored and distributed...
Generic medicines are copies of original, branded medicines. They can be manufactured and sold after the protection on an original product expires. They have the same form and active...
